What Is Continuous Glucose Monitoring (CGM)?
Continuous glucose monitoring (CGM) is a process that uses wearable technology to track glucose levels in real time, giving ongoing insights into how glucose changes throughout the day and night, often with fewer fingerprick checks. By providing continuous data and trend information, CGM can help people make more informed decisions about food, activity, and insulin.1
Considering CGM use is an important step in understanding and managing diabetes more effectively. In this article, you’ll learn how CGMs work, the benefits they offer, and how they can help support everyday decisions around food, physical activity, and insulin.
How does Continuous Glucose Monitoring work?
A CGM system continuously measures glucose levels and shares that information with a display device (such as a smartphone app or a dedicated receiver), allowing you to see not just your current glucose level, but also where it’s heading.
Most systems include three main components:
The sensor
A sensor is worn on the body and held in place with an adhesive patch. A thin, thread-like filament sits just under the skin and measures glucose in the interstitial fluid (the fluid around your cells) every few minutes.
The transmitter
The transmitter sends glucose readings wirelessly from the sensor to your display device, such as a smartphone app or dedicated receiver. In many systems, the transmitter is built into the sensor.
Smartphone app or receiver
Glucose data is displayed on a smartphone app or dedicated receiver. This allows you to:
- See your current glucose reading
- View trend arrows (rising, falling, steady)
- Review patterns over time
Some systems also allow data sharing with caregivers or healthcare providers.
Continuous Glucose Monitoring vs. fingerstick testing
CGM and fingerstick testing (using a blood glucose meter) both measure glucose levels, but they provide different types of information and are used in different ways. Fingerstick testing offers a single reading at a specific point in time, while CGM provides a more continuous view of glucose levels and trends, including how they change throughout the day.
CGM reduces the need for frequent fingerpricks, but occasional checks may still be needed, such as when symptoms don’t match readings.1
What are the benefits of Continuous Glucose Monitoring?
CGM is designed to provide both day-to-day convenience and long-term health insights. By combining real-time data with trends, it can help people better understand and manage their diabetes.
Lifestyle benefits
- Quickly check glucose levels at any time
- See whether levels are rising, falling, or stable
- Access data on a smartphone or smartwatch
- Share glucose data with family or caregivers
- Receive alerts for high or low glucose levels, including overnight
Clinical benefits
Real-time glucose visibility can enable more timely action, which may help support the clinical benefits below. 2
- Reduced HbA1c in people living with diabetes
- Increased glucose time in range
- Reduced duration and incidence of hypoglycemia
What are the limitations of Continuous Glucose Monitoring?
While CGM offers many benefits, it’s important to understand its limitations to set realistic expectations.
Accuracy and lag time
CGM measures glucose in interstitial fluid, not blood. This can cause a slight delay, especially when glucose changes quickly.
Skin irritation and replacement
Sensors must be worn on the skin and replaced regularly. Some people may experience mild skin irritation.
Cost and access
Access to the devices can depend on private insurance coverage and provincial health programs. Eligibility and out-of-pocket costs may vary by province, insurance provider, and individual policy.
Data overload
The amount of data available can feel overwhelming at first, especially for new users learning how to interpret trends.
Alarm fatigue
Frequent alerts for highs or lows can sometimes feel disruptive, particularly overnight.
Who should use Continuous Glucose Monitoring?
A wide range of people living with diabetes can benefit from CGM, depending on their treatment plan and individual needs.2
People with type 1 diabetes
Continuous glucose monitoring is widely recommended for people with type 1 diabetes, as it can help improve glucose control, reduce hypoglycemia, and support daily decision-making.2
People with type 2 diabetes
For people using insulin, this type of monitoring may help improve glucose management, increase time in range, and it has been shown to reduce A1C in adults with type 2 diabetes.2 Some people who do not use insulin may also benefit depending on their goals.3
Children
CGM can help children and families monitor glucose levels more closely, including overnight, and reduce worry about low glucose events.
Caregivers
Many systems allow remote data sharing, enabling parents, partners, or caregivers to monitor glucose levels and receive alerts.
How does a CGM help with diabetes management?
Continuous glucose monitoring provides detailed insights that can support day-to-day diabetes decisions and long-term management.
It can help you:
- Understand how food affects glucose levels
- Inform adjustment of insulin dosing (with healthcare guidance)
- Monitor glucose during exercise or illness
- Identify patterns across different times of day
- Make more informed decisions about treating highs and lows
Over time, this information can help you and your healthcare team make more personalized adjustments to your care plan.
Continuous Glucose Monitoring and Pod therapy
CGM plays a key role in systems that combine glucose monitoring with insulin delivery. When paired with a compatible insulin pump, CGM data can be used to automatically adjust insulin in response to changing glucose levels.
Learn about CGM compatibility with Omnipod®.
How do CGMs work with insulin pumps?
Continuous glucose monitors can be used on their own or alongside an insulin pump. When combined, they form the foundation of automated insulin delivery (AID) systems.
CGM and insulin pump communication
In connected systems, the CGM sends glucose data directly to the pump or controller.
Automated Insulin Delivery (AID) basics
An AID system uses a CGM, insulin pump, and algorithm to automatically adjust insulin delivery based on glucose levels.
Role of CGM in adjusting insulin
Monitors provide real-time data needed for the system to:
- Detect rising or falling glucose
- Communicate with the AID system to adjust basal insulin
What’s the difference between a flash glucose sensor and a Continuous Glucose Monitor?
Continuous glucose monitors and flash glucose sensors both track glucose levels throughout the day, but they differ in how data is accessed and shared. Some systems automatically display glucose readings and alerts, while others require scanning the sensor to view current levels and trends.
Both technologies can support good diabetes management.
About Omnipod® 5
The Omnipod® 5 Automated Insulin Delivery System is an example of an automated insulin delivery system that connects a wearable, waterproof,* and tubeless insulin pump with a compatible continuous glucose monitor.
The Omnipod 5 algorithm is built right into the Pod. The system adjusts insulin delivery based on glucose readings and trends, while still allowing users to bolus for meals.
Frequently Asked Questions about CGMs
Does continuous glucose monitoring replace fingerpricks?
How does a CGM differ from a blood glucose meter?
How often do you have to change a CGM sensor?
Where can I wear a CGM sensor?
Can I share my glucose data with friends and family?
Related Articles
Other topics
References and Disclaimers
* The Pod has an IP28 rating for up to 7.6 metres (25 feet) for up to 60 minutes. The Controller is not waterproof.
1.CDC. Continuous Glucose Monitors. Diabetes. Published November 13, 2025. https://www.cdc.gov/diabetes/treatment/continuous-glucose-monitors.html
2. Berard L, Siemens R, Woo V. (2018). Monitoring Glycemic Control. Canadian Journal of Diabetes, 42(1), S47-S53.
3. Cheng A, Feig D, Ho J, Siemens R, Bajaj H, Gilbert J, Houlden R, Kim J, Mackay D, Rabi D, Senior P, Sherifali D. (2021). Blood glucose monitoring in adults and children with diabetes: Update 2021. Canadian Journal of Diabetes, 45(7), 580–587.
The Omnipod® 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin.
The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM). When in automated mode, the Omnipod 5 system is designed to assist people with type 1 diabetes in achieving glycemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or pause) insulin delivery to operate within predefined threshold values using current and predicted CGM values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycemia and hypoglycemia.
The Omnipod 5 System can also operate in a manual mode that delivers insulin at set or manually adjusted rates.
The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®/NovoRapid®, Humalog® / Liprolog®, Admelog® / Insulin lispro Sanofi®, Trurapi® / Insulin aspart Sanofi®, and Kirsty® U-100 insulin.
Warning: The Omnipod 5 System should NOT be used by anyone under the age of 2 years old. The Omnipod 5 System should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea and using a Dexcom Sensor as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components.
Warning: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.